NAD+/MOTS-c/5-Amino-1MQ - bad idea?

[NewHealth99]

Run 5-Amino-1MQ and MOTS-C separately - they don't mix in the same solution.

 

[Wild_Set]

Tesa, 5-Amino-1MQ, and MOTS-C together covers the combination that makes practical sense - each has a defined mechanism and they don't compete.

 

[slim_sketcher]

NAD+ precursors and MOTS-c have solid mechanism rationale individually but the combination evidence base is essentially anecdotal. 5-Amino-1MQ's data is even thinner. None of these have meaningful head-to-head comparison data that would let you evaluate whether the stack outperforms any single component.

 

[quietdate55]

the large pharma association is usually a good sign for basic sterility and consistency but it doesn't mean immune to quality issues - even branded products have had recalls, and the reason tends to be discovered after the fact rather than caught prospectively. for peptide combinations specifically the interaction data is thin regardless of who makes the individual components

 

[sandy_thyme84]

the mixing concern breaks down into two categories - chemical compatibility (whether the compounds destabilize each other in solution at the same pH and salt concentration) and practical accuracy (whether drawing multiple compounds in the same syringe creates dosing errors). most commonly stacked peptides are compatible enough in solution to be mixed, but there are compound-specific exceptions worth confirming before assuming the general case applies to a specific stack